{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:33:17Z","timestamp":1765438397625},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T00:00:00Z","timestamp":1426032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00296-015-3239-8","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T15:08:56Z","timestamp":1426000136000},"page":"1503-1510","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Staphylococcus aureus sepsis in rheumatoid arthritis"],"prefix":"10.1007","volume":"35","author":[{"given":"Michael","family":"Sams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reeti","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabha","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,11]]},"reference":[{"key":"3239_CR1","doi-asserted-by":"crossref","first-page":"e71055","DOI":"10.1371\/journal.pone.0071055","volume":"8","author":"CH Su","year":"2013","unstructured":"Su CH, Chang SC, Yan JJ, Tseng SH, Chien LJ, Fang CT (2013) Excess mortality and long-term disability from healthcare-associated Staphylococcus aureus infections: a population-based matched cohort study. PLoS One 8:e71055","journal-title":"PLoS One"},{"key":"3239_CR2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","volume":"29","author":"A Hidron","year":"2008","unstructured":"Hidron A, Edwards J, Patel J et al (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006\u20132007. Infect Control Hosp Epidemiol 29:996\u20131011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3239_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/SMJ.0b013e318287fe71","volume":"106","author":"V Fleming","year":"2013","unstructured":"Fleming V, Buck B, Nix N, Kumar P, Southwood R (2013) Community-acquired pneumonia with risk for drug-resistant pathogens. South Med J 106:209\u2013216","journal-title":"South Med J"},{"key":"3239_CR4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jac\/dkt016","volume":"68","author":"O Gasch","year":"2013","unstructured":"Gasch O, Camoez M, Dom\u00ednguez MA, Padilla B (2013) Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 68:1423\u20131430","journal-title":"J Antimicrob Chemother"},{"key":"3239_CR5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1469-0691.2011.03679.x","volume":"18","author":"M Bassetti","year":"2012","unstructured":"Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M et al (2012) Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microb Infect 18:862\u2013869","journal-title":"Clin Microb Infect"},{"key":"3239_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/00365540600810026","volume":"39","author":"G Jacobsson","year":"2007","unstructured":"Jacobsson G, Dashti S, Wahlberg T, Andersson R (2007) The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 39:6\u201313","journal-title":"Scand J Infect Dis"},{"key":"3239_CR7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287\u20132293","journal-title":"Arthritis Rheum"},{"key":"3239_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MD.0b013e318211106a","volume":"90","author":"MA Lane","year":"2011","unstructured":"Lane MA, McDonald JR, Zeringue AL, Caplan L, Curtis JR, Ranganathan P et al (2011) TNF-\u03b1 antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine 90:139\u2013145","journal-title":"Medicine"},{"key":"3239_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2106\/JBJS.F.01515","volume":"90","author":"MA Olsen","year":"2008","unstructured":"Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield JL et al (2008) Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg 90:62\u201369","journal-title":"J Bone Joint Surg"},{"key":"3239_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/587810","volume":"29","author":"MA Olsen","year":"2008","unstructured":"Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ (2008) Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol 29:477\u2013484","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3239_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/663715","volume":"33","author":"JD Lankiewicz","year":"2012","unstructured":"Lankiewicz JD, Yokoe DS, Olsen MA, Onufrak F, Fraser VJ, Stevenson K et al (2012) Beyond 30\u00a0days: does limiting the duration of SSI follow-up limit detection? Infect Control Hosp Epidemiol 33:202\u2013204","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3239_CR12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2334-14-306","volume":"14","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER (2014) Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 14:306","journal-title":"BMC Infect Dis"},{"key":"3239_CR13","doi-asserted-by":"crossref","first-page":"K41","DOI":"10.1016\/j.vaccine.2013.03.075","volume":"31S","author":"CP Chung","year":"2013","unstructured":"Chung CP, Rohan P, Krishnaswami S, McPheeters ML (2013) A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data. Vaccine 31S:K41\u2013K61","journal-title":"Vaccine"},{"key":"3239_CR14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546\u20131554","journal-title":"N Engl J Med"},{"key":"3239_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613\u2013619","journal-title":"J Clin Epidemiol"},{"key":"3239_CR16","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP (2006) British Society for Rheumatology Biologics Register. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54:2368\u20132376","journal-title":"Arthritis Rheum"},{"key":"3239_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.23396","volume":"58","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Lunt M, Schneeweiss S (2008) The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence. Arthritis Rheum 58:919\u2013928","journal-title":"Arthritis Rheum"},{"key":"3239_CR18","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2008.102715","volume":"68","author":"N Akhmed","year":"2009","unstructured":"Akhmed N, Lichtenstein J (2009) MRSA infections in patients treated with tumour necrosis factor inhibitors. Ann Rheum Dis 68:1788\u20131789","journal-title":"Ann Rheum Dis"},{"key":"3239_CR19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jinf.2013.07.027","volume":"67","author":"P Loulergue","year":"2013","unstructured":"Loulergue P, Tubach F, Salmon D, Dellamonica P, Taillan B, Thorel JB, Ratio Group et al (2013) Bacteremia in patients receiving TNF-alpha antagonists\u2014a prospective multicenter study. J Infect 67:524\u2013528","journal-title":"J Infect"},{"key":"3239_CR20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285","journal-title":"JAMA"},{"key":"3239_CR21","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","volume":"306","author":"CG Grijalva","year":"2011","unstructured":"Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL et al (2011) Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 306:2331\u20132339","journal-title":"JAMA"},{"key":"3239_CR22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1699-258X(08)76163-1","volume":"4","author":"RA Alonso","year":"2008","unstructured":"Alonso RA (2008) Infections in patients with rheumatoid arthritis undergoing anti-TNF\u03b1 drug therapy. Reumatol Clin 4:18\u201323","journal-title":"Reumatol Clin"},{"key":"3239_CR23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","volume":"68","author":"JP Leombruno","year":"2009","unstructured":"Leombruno JP, Einarson TR, Keystone EC (2009) The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 68:1136\u20131145","journal-title":"Ann Rheum Dis"},{"key":"3239_CR24","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","volume":"163","author":"VG Fowler Jr","year":"2003","unstructured":"Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066\u20132072","journal-title":"Arch Intern Med"},{"key":"3239_CR25","doi-asserted-by":"crossref","first-page":"e46389","DOI":"10.1371\/journal.pone.0046389","volume":"7","author":"KH Park","year":"2012","unstructured":"Park KH, Lee YM, Hong HL, Kim T, Park HJ, Park SY et al (2012) Persistent catheter-related Staphylococcus aureus Bacteremia after catheter removal and initiation of antimicrobial therapy. PLoS One 7:e46389","journal-title":"PLoS One"},{"key":"3239_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","volume":"92","author":"YP Chong","year":"2013","unstructured":"Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Park KH et al (2013) Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine 92:98\u2013108","journal-title":"Medicine"},{"key":"3239_CR27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.1666","volume":"311","author":"PN Malani","year":"2014","unstructured":"Malani PN (2014) National burden of invasive methicillin-resistant Staphylococcus aureus infection. JAMA 311:1438\u20131439","journal-title":"JAMA"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3239-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3239-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:28:29Z","timestamp":1559042909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3239-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,11]]}}}